Abstract:Introduction: Moyamoya disease (MMD) is a rare and chronic cerebrovascular disease characterized by progressive stenosis or occlusion of the blood vessels within the terminal intracranial aspect of the internal carotid artery and the circle of Willis, leading to the compensatory development of a fragile collateral vessel network at the base of the brain. These vascular features are responsible for the recurrent ischemic and/or hemorrhagic strokes seen in affected patients. Numerous studies have attempted to clarify the clinical features of Moyamoya, including its etiopathology and interventions. In recent years, the development of neuroimaging and surgical techniques has enhanced the understanding of MMD in patients. The purpose of this review is to discuss the hypothesized etiopathogenesis, clinical manifestations, and the current possible treatment options available for Moyamoya disease. Methods: The PRISMA protocol was utilized to perform an extensive literature search on Google Scholar, Scopus, Web of Science, and PubMed for articles about etiopathogenesis and clinical presentation of Moyamoya disease and the treatment protocols followed in different parts of the world. A comprehensive analysis was also conducted for original articles to better understand the possible clinical presentation and diagnostic criteria used. Results: Based on the literature review, the RNF213 mutation, mitochondrial dysfunction, and misregulation of growth factors in endothelial cells are the most acceptable etiopathogenesis of MMD via their involvement in neurovascular inflammation. Conclusion: The diagnostic test of choice is magnetic resonance angiography while direct & indirect revascularization surgeries are both effective and established treatments for managing symptoms of Moyamoya disease.
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to explore the etiological and pathological mechanisms of Moyamoya disease (MMD) and its treatment methods. Specifically:
1. **Etiological and pathological mechanisms**: The paper aims to discuss and summarize the current hypotheses regarding the etiology and pathology of MMD, including mechanisms such as RNF213 gene mutations, endothelial cell mitochondrial dysfunction, and endothelial cell growth factor dysregulation, and how these mechanisms lead to the occurrence of MMD by participating in neurovascular inflammation.
2. **Clinical manifestations**: The paper also explores the clinical manifestations of MMD, such as transient ischemic attacks (TIA), ischemic or hemorrhagic strokes, epilepsy, infarctions, headaches, cognitive impairments, etc., and analyzes the differences in clinical characteristics among patients of different ages and genders.
3. **Diagnostic methods**: The paper summarizes the various imaging techniques currently used to diagnose MMD, including traditional cerebral angiography, magnetic resonance angiography (MRA), computed tomography (CT), positron emission tomography (PET), electroencephalogram (EEG), etc., and emphasizes the importance and application of MRA in diagnosis.
4. **Treatment methods**: The paper discusses the currently available MMD treatment options, including drug treatment, endovascular treatment (EVT), and surgical treatment. Among them, surgical treatment is the most effective method for managing symptoms, mainly divided into three methods: direct revascularization, indirect revascularization, and combined revascularization. The paper also compares the advantages and disadvantages of these three surgical methods and points out that the most appropriate treatment plan should be selected according to the specific situation of the patient.
In summary, the main purpose of this paper is to comprehensively review and summarize the etiology, pathology, clinical manifestations, diagnostic methods, and treatment methods of MMD, in order to provide more comprehensive reference information for clinicians and improve the management and treatment effects of MMD patients.